SEC Form 5/A · accession 0001387131-16-004273
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Dennis J Carlo Ph.D.
Officer — President & CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 16, 2016 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2014 | G | 20,000 | $0.00 | D | 13,896 | D | |
| Common Stock | Feb 27, 2014 | G | 4,119 | $0.00 | D | 13,896 | D | |
| Common Stock | Feb 27, 2014 | G | 408,709 | $0.00 | D | 13,896 | D | |
| Common Stock | Feb 27, 2014 | G | 408,709 | $0.00 | A | 408,709 | I | By D. Carlo and A. Carlo Joint Living Trust |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The Reporting Person's original Form 5, filed with the Securities and Exchange Commission on February 17, 2015, did not include 4,386 shares of common stock that were issuable in the future upon the vesting of then-unvested Restricted Stock Units held directly by the Reporting Person as of December 31, 2014, and reported shares of common stock as directly owned by the Reporting Person rather than as indirectly owned by a family trust, as reflected in this amended Form 5.